留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

乙肝病毒感染对妊娠及母婴的影响

张鑫,  王金亮

downloadPDF
文章导航 > 分子影像学杂志  > 2015 >  38(1): 16-20
张鑫, 王金亮. 乙肝病毒感染对妊娠及母婴的影响[J]. 分子影像学杂志, 2015, 38(1): 16-20. doi: 10.3969/j.issn.1674-4500.2015.01.05
引用本文: 张鑫, 王金亮. 乙肝病毒感染对妊娠及母婴的影响[J]. 分子影像学杂志, 2015, 38(1): 16-20. doi: 10.3969/j.issn.1674-4500.2015.01.05
shu
Xin ZHANG, Jinliang WANG. Hepatitis b virus infection on pregnancy and study the influence of the mother and baby[J]. Journal of Molecular Imaging, 2015, 38(1): 16-20. doi: 10.3969/j.issn.1674-4500.2015.01.05
Citation: Xin ZHANG, Jinliang WANG. Hepatitis b virus infection on pregnancy and study the influence of the mother and baby[J]. Journal of Molecular Imaging, 2015, 38(1): 16-20. doi: 10.3969/j.issn.1674-4500.2015.01.05
shu

乙肝病毒感染对妊娠及母婴的影响

doi: 10.3969/j.issn.1674-4500.2015.01.05

  • 烟台市传染病医院检验科，山东 烟台 264001

详细信息
    作者简介:

    张鑫，E-mail: zxcongufo@163.com

Hepatitis b virus infection on pregnancy and study the influence of the mother and baby

  • Clinical laboratory of Yantai Infectious Hospital, Yantai 264001, China

    摘要
  • 摘要: 我国是慢性乙型肝炎病毒(HBV)感染高发地区，全球大约有4亿慢性乙肝病毒感染者，而我国约有1.2亿病例，其中约有一半是通过母婴传播形成的，尤其是在乙肝比较流行的地区。本文就与乙肝病毒感染和妊娠相关的几个主要问题包括怀孕对慢性乙肝病毒感染的影响、母婴传播、HBV感染孕妇的相关安全数据以及乙肝病毒携带孕妇的管理进行论述。以期为阻断乙型肝炎病毒母婴传播进一步研究提供参考。

     

    Abstract: China is chronic hepatitis b virus (HBV) infection in high-risk areas, the world is about 400 million chronic hepatitis b virus infection, and there are about 120 million cases in our country, about half is formed through mother-to-child transmission, especially in hepatitis b relatively popular in the region. Associated with hepatitis b virus infection and pregnancy in this paper, several key problems including pregnancy for chronic hepatitis b virus infection, mother-to-child transmission, the influence of the relevant safety data of HBV infection in pregnant women and second liver virus carried, the essay discusses the management of pregnant women. In order to block mother-to-child transmission of hepatitis b virus to provide the reference for further research.

     

    • HTML全文
    • 参考文献(18)
  • [1] Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT[J]. Gastroenterology, 2008, 134(5): 1376-84. doi: 10.1053/j.gastro.2008.02.075
    [2] Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures [J]. J Viral Hepat, 2004, 11(2): 97-107. doi: 10.1046/j.1365-2893.2003.00487.x
    [3] Gambarin-Gelwan M. Hepatitis B in pregnancy[J]. Clin Liver Dis, 2007, 11(4): 945-63. doi: 10.1016/j.cld.2007.08.004
    [4] Mahtab MA, Rahman S, Khan M, et al. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh [J]. Hepatobiliary Pancreat Dis Int, 2008, 7(2): 161-4. https://www.ncbi.nlm.nih.gov/pubmed/18397851
    [5] ter Borg MJ, Leemans WF, de Man RA, et al. Exacerbation of chronic hepatitis B infection after delivery[J]. J Viral Hepat, 2008, 15(1): 37-41. https://www.ncbi.nlm.nih.gov/pubmed/18088243
    [6] Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection [J]. Hepatol Res, 2010, 40(1): 31-48. doi: 10.1111/hep.2010.40.issue-1
    [7] Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an Independent risk factor for adverse perinatal outcome [J]. Liver Int, 2010, 30(5): 765-70. doi: 10.1111/liv.2010.30.issue-5
    [8] Elefsiniotis IS, Tsoumakas K, Papadakis M, et al. Importance of maternal and cord blood viremia in pregnant women with chronic hepatitis B virus infection [J]. Eur J Intern Med, 2011, 22(2): 182-6. doi: 10.1016/j.ejim.2010.12.005
    [9] Shi Z, Yang Y, Ma L, et al. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis [J]. Obstet Gynecol, 2010, 116(1): 147-59. doi: 10.1097/AOG.0b013e3181e45951
    [10] Chen HL, Chang CJ, Kong MS, et al. Fulminant hepatic failure in children in endemic area of hepatitis B virus infection:15 years after Universal hepatitis B vaccination [J]. Hepatology, 2004, 39(1): 58-63. doi: 10.1002/(ISSN)1527-3350
    [11] Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers [J]. J Viral Hepat, 2012, 19(2): e18-25. doi: 10.1111/j.1365-2893.2011.01492.x
    [12] Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants [J]. J Viral Hepat, 2011, 18 (7): 468-73. doi: 10.1111/jvh.2011.18.issue-7
    [13] Liu Y, Kuang J, Zhang R, et al. Analysis about clinical data of intrauterine infection of hepatitis B virus [J]. Zhonghua Fu Chan Ke Za Zhi, 2002, 37(8): 465-8. http://europepmc.org/abstract/med/12411025
    [14] Bai GQ, Li SH, Yue YF, et al. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection[J]. Arch Gynecol Obstet, 2011, 283(2): 317-21. doi: 10.1007/s00404-010-1366-8
    [15] Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier motherss [J]. Int J Clin Pract, 2003, 57(3): 100-2. https://www.ncbi.nlm.nih.gov/pubmed/12661791
    [16] 张丽菊, 王玲.替比夫定对妊娠后期乙型肝炎病毒宫内感染的阻断作用[J].中华肝病杂志, 2009, 17(2): 561-3. http://www.cqvip.com/qk/90483a/200908/31282931.html
    [17] Yang J, Zeng XM, Men YL, et al. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus -a systematic review [J]. Virol J, 2008, 5(1): 100-7. doi: 10.1186/1743-422X-5-100
    [18] Lee C, Gong Y, Brok J, et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis[J]. BMJ, 2006, 332(7537): 328-36. doi: 10.1136/bmj.38719.435833.7C
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  697
  • HTML全文浏览量:  246
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-12-01
  • 刊出日期:  2015-05-15

目录

    /

    返回文章
    返回
    • 版权所有© 2013《分子影像学杂志》编辑部 ICP备00000000号
    • 重点提示: Adobe Reader6可能造成全文显示不正常，请升级为Adobe Reader7或更高。
    • 地址: 广东省广州市广州大道北1838号 Tel: 020-61648176 E-mail: 

    本系统由 北京仁和汇智信息技术有限公司 开发  技术支持：info@rhhz.net

    x 关闭 永久关闭

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者：

    为了缩短出版时滞，促进科研成果的快速传播，我刊自2024年1月起，刊期由双月刊变更为月刊。本刊主要栏目有：基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱！

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日